Logotype for Nephros Inc

Nephros (NEPH) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Nephros Inc

Q2 2026 earnings summary

1 Sep, 2026

Executive summary

  • Achieved record net revenue of $6 million for Q2 2026, a 36% increase year-over-year, with net income rising to $1.2 million from $0.2 million in Q2 2025, aided by a one-time $0.6 million tariff refund.

  • Growth was broad-based across core programmatic products, services, and emergency response, with service revenue nearly tripling year-over-year and core programmatic revenue up 27%.

  • Recent product launches and expanded service offerings contributed to growth and market expansion, with the business evolving into an integrated water safety platform.

  • Revenue for the first six months of 2026 rose 21% to $11.2 million, reflecting diversification across channels.

  • The company operates a single segment focused on high-performance water filtration solutions for medical and commercial markets.

Financial highlights

  • Q2 2026 net revenue: $6 million (up from $4.4 million in Q2 2025); gross margin for Q2 2026 was 67%, up from 63% in Q2 2025, primarily due to a $600,000 tariff refund.

  • Net income for Q2 2026 increased over 400% to $1.2 million; adjusted EBITDA rose 260% to $1.3 million.

  • Six-month net income increased 68% to $1.3 million; adjusted EBITDA up 46% to $1.5 million.

  • Ended Q2 2026 with $4.7 million in cash and no debt; working capital increased to $10.3 million, and stockholders’ equity rose to $12.0 million.

  • Q2 2026 EPS (basic and diluted): $0.11; six-month EPS: $0.12.

Outlook and guidance

  • Expectation for continued growth driven by core programmatic products, expanding service offerings, and new products addressing PFAS, microplastics, and nanoplastics.

  • Margin improvement remains a focus, with ongoing evaluation of pricing, sourcing, and operational efficiencies.

  • Management expects sufficient liquidity to fund operations for at least the next 12 months, with a focus on revenue growth and expense control.

  • Gross margins may face headwinds due to ongoing U.S. tariff policy despite the recent refund.

  • Investments in technology and service platform position the company for long-term shareholder value.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Nephros